Literature DB >> 28776141

Vonoprazan-Based Helicobacter pylori Eradication Therapy: Time to Get Kompetitive?

Eun Hye Kim1, Chan Hyuk Park2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28776141     DOI： 10.1007/s10620-017-4699-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

Review 1.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 2.  Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition.

Authors:  Sang Gyun Kim; Hye-Kyung Jung; Hang Lak Lee; Jae Young Jang; Hyuk Lee; Chan Gyoo Kim; Woon Geon Shin; Ein Soon Shin; Yong Chan Lee
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

Review 3.  Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.

Authors:  Yoon Suk Jung; Chan Hyuk Park; Jung Ho Park; Eunwoo Nam; Hang Lak Lee
Journal:  Helicobacter       Date:  2017-04-19       Impact factor: 5.753

Review 4.  Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.

Authors:  Hiroki Tanabe; Katsuyoshi Ando; Kiichi Sato; Takahiro Ito; Mitsuru Goto; Tomonobu Sato; Akihiro Fujinaga; Toru Kawamoto; Tatsuya Utsumi; Nobuyuki Yanagawa; Eiichiro Ichiishi; Takaaki Otake; Yutaka Kohgo; Yoshiki Nomura; Nobuhiro Ueno; Hiroko Sugano; Shin Kashima; Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Dig Dis Sci       Date:  2017-06-29       Impact factor: 3.199

Review 5.  Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.

Authors:  Y S Jung; E H Kim; C H Park
Journal:  Aliment Pharmacol Ther       Date:  2017-05-12       Impact factor: 8.171

Review 6.  Helicobacter pylori eradication for the prevention of gastric neoplasia.

Authors:  Alexander C Ford; David Forman; Richard Hunt; Yuhong Yuan; Paul Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

7.  A report card to grade Helicobacter pylori therapy.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2007-08       Impact factor: 5.753

Review 8.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

Review 9.  Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.

Authors:  Bao-Zhu Li; Diane Erin Threapleton; Ji-Yao Wang; Jian-Ming Xu; Jin-Qiu Yuan; Chao Zhang; Peng Li; Qian-Ling Ye; Biao Guo; Chen Mao; Dong-Qing Ye
Journal:  BMJ       Date:  2015-08-19

10.  Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.

Authors:  Kazunari Murakami; Yuuichi Sakurai; Madoka Shiino; Nobuo Funao; Akira Nishimura; Masahiro Asaka
Journal:  Gut       Date:  2016-03-02       Impact factor: 23.059
View more
  1 in total

Review 1.  Potent Acid Suppression with PPIs and P-CABs: What's New?

Authors:  Richard H Hunt; Carmelo Scarpignato
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.